Sign In

Login

Password

Forgot Password ? Sign Up

Altretamine (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Altretamine" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
6nih.gov
4th place
7th place
5doi.org
2nd place
2nd place
1archive.org
6th place
4th place
1drugs.com
399th place
214th place

archive.org (Global: 6th place; Vietnamese: 4th place)

doi.org (Global: 2nd place; Vietnamese: 2nd place)

  • Keldsen N, Havsteen H, Vergote I, Bertelsen K, Jakobsen A (2003). "Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study". Gynecol. Oncol. Quyển 88 số 2. tr. 118–22. doi:10.1016/S0090-8258(02)00103-8. PMID 12586589.
  • Chan JK, Loizzi V, Manetta A, Berman ML (2004). "Oral altretamine used as salvage therapy in recurrent ovarian cancer". Gynecol. Oncol. Quyển 92 số 1. tr. 368–71. doi:10.1016/j.ygyno.2003.09.017. PMID 14751188.
  • Malik IA (2001). "Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer". Jpn. J. Clin. Oncol. Quyển 31 số 2. tr. 69–73. doi:10.1093/jjco/hye012. PMID 11302345.
  • Damia G, D'Incalci M (1995). "Clinical pharmacokinetics of altretamine". Clinical Pharmacokinetics. Quyển 28 số 6. tr. 439–48. doi:10.2165/00003088-199528060-00002. PMID 7656502.
  • Wiernik, P. H.; Yeap, B.; Vogl, S. E.; Kaplan, B. H.; Comis, R. L.; Falkson, G.; Davis, T. E.; Fazzini, E.; Cheuvart, B. (1992). "Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: A study of the Eastern Cooperative Oncology Group". Cancer investigation. Quyển 10 số 1. tr. 1–9. doi:10.3109/07357909209032783. PMID 1735009.

drugs.com (Global: 399th place; Vietnamese: 214th place)

nih.gov (Global: 4th place; Vietnamese: 7th place)

pubmed.ncbi.nlm.nih.gov

  • Keldsen N, Havsteen H, Vergote I, Bertelsen K, Jakobsen A (2003). "Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study". Gynecol. Oncol. Quyển 88 số 2. tr. 118–22. doi:10.1016/S0090-8258(02)00103-8. PMID 12586589.
  • Chan JK, Loizzi V, Manetta A, Berman ML (2004). "Oral altretamine used as salvage therapy in recurrent ovarian cancer". Gynecol. Oncol. Quyển 92 số 1. tr. 368–71. doi:10.1016/j.ygyno.2003.09.017. PMID 14751188.
  • Malik IA (2001). "Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer". Jpn. J. Clin. Oncol. Quyển 31 số 2. tr. 69–73. doi:10.1093/jjco/hye012. PMID 11302345.
  • Damia G, D'Incalci M (1995). "Clinical pharmacokinetics of altretamine". Clinical Pharmacokinetics. Quyển 28 số 6. tr. 439–48. doi:10.2165/00003088-199528060-00002. PMID 7656502.
  • Wiernik, P. H.; Yeap, B.; Vogl, S. E.; Kaplan, B. H.; Comis, R. L.; Falkson, G.; Davis, T. E.; Fazzini, E.; Cheuvart, B. (1992). "Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: A study of the Eastern Cooperative Oncology Group". Cancer investigation. Quyển 10 số 1. tr. 1–9. doi:10.3109/07357909209032783. PMID 1735009.

dailymed.nlm.nih.gov

  • "Hexalen (altretamine) Capsule. Human Prescription Drug Label". dailymed.nlm.nih.gov. Eisai Inc. Truy cập ngày 24 tháng 8 năm 2016.